Rapid detection of VHL exon deletions using real-time quantitative PCR

Laboratory Investigation

Volumn 85, Issue 1, 2005, Pages 24-33

  Hoebeeck, Jasmien ^a   Van Der Luijt, Rob ^b   Poppe, Bruce ^a   De Smet, Els ^a   Yigit, Nurten ^a   Claes, Kathleen ^a   Zewald, Richard ^b   De Jong, Gert Jan ^b   De Paepe, Anne ^a   Speleman, Frank ^a   Vandesompele, Jo ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Exon deletion; Molecular diagnostics; Real time quantitative PCR (Q PCR); SYBR green I; VHL

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOMINANT INHERITANCE; EXON; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEMANGIOBLASTOMA; HUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; SOUTHERN BLOTTING; VON HIPPEL LINDAU DISEASE;

EXONS; GENE DELETION; GENETIC SCREENING; HIPPEL-LINDAU DISEASE; HUMANS; ORGANIC CHEMICALS; POINT MUTATION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 19944431363     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700209     Document Type: Article

References (24)

1. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994;91:9700-9704.
2. Prowse AH, Webster AR, Richards FM, et al. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors. Am J Hum Genet 1997;60:765-771.
3. Maher ER, Webster AR, Richards FM, et al. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 1996;33:328-332.
4. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998;12:417-423.
5. Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996;8:348-357.
6. Stenson PD, Ball EV, Mort M, et al. Human gene mutation database (HGMD): 2003 update. Hum Mutat 2003;21:577-581.
7. Yao M, Latif F, Orcutt ML, et al, von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis. Hum Genet 1993;92:605-614.
8. Richards FM, Phipps ME, Latif F, et al. Mapping the von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993;2:879-882.
9. Decker HJ, Klauck SM, Lawrence JB, et al. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL). Cancer Genet Cytogenet 1994;77:1-13.
10. Pack SD, Zbar B, Pak E, et al. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 1999;59:5560-5564,
11. Phipps ME, Maher ER, Affara NA, et al. Physical mapping of chromosome 3p25-p26 by fluorescence in situ hybridisation (FISH), Hum Genet 1993;92:18-22.
12. Cybulski C, Krzystolik K, Maher ER, et al. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Hum Genet 1999;105:333-336.
13. Armour JA, Sismani C, Patsalis PC, et al. Measurement of locus copy number by hybridisation with amplifiable probes. Nucl Acids Res 2000;28:605-609.
14. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucl Acids Res 2002;30:e57.
15. De Preter K, Speleman F, Combaret V, et al. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002;15:159-166.
16. Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-1163.
17. Maher ER, Kaelin Jr WG. von Hippel-Lindau disease. Medicine (Baltimore) 1997;76:381-391.
18. Gnarra JR, Duan DR, Weng Y, et al. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996;1242:201-210.
19. Pattyn F, Speleman F, De Paepe A, et al. RTPrimerDB: the real-time PCR primer and probe database. Nucl Acids Res 2003;31:122-123.
20. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
22. Boeckman F, Hamby K, Tan L. Real-time PCR using the iCycler iQ detection system and intercalating dyes. Tech note 2620.
23. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucl Acids Res 2003;31:3406-3415.
24. Sellner LN, Taylor GR. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 2004;23:413-419.